Dose-Response Study of Iocide Oral Rinse

NCT01103102 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Gingivitis

Interventions

DRUG: Iocide Oral Rinse
DRUG: Placebo

Sponsor

Biomedical Development Corporation

Collaborators

[object Object]
[object Object]